Medical/Pharmaceuticals
Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts
HYDERABAD, India and BOSTON, May 25, 2022 /PRNewswire/ -- Excelra, a leading global data and digital insights organization, today announced a partnership with HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for th...
The Centre for Probe Development and Commercialization expands into Asia and executes a development, manufacturing, and clinical supply agreement for 177Lu-PSMA (DGUL) With South Korea-based CellBion
HAMILTON, ON, May 25, 2022 /PRNewswire/ -- The Centre for Probe Development and Commercialization (CPDC) is pleased to announce the initiation of a development, manufacturing, and supply agreement withCellBion for Lu-177-radiolabelled PSMA (DGUL) therapeutic agent. Under the terms of the agreeme...
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic
Includes asymptomatic testing at community-based facilities to prevent widespread transmissions Regular testing for COVID-19, flu, RSV crucial for staying safe as anti-virus restrictions are eased PCR tests will be priced affordably, made possible through Seegene's 20 years of expertise "Full ...
Dr Ivan Puah Expands Service To Sports Aesthetics® To Meet Demands Of Sportspeople
Sports aesthetics® is a term coined by Dr Ivan Puah based on the three pillars of combining unique service offerings to help fitness enthusiasts, sportspeople and professional athletes attain their ideal physiques without compromising the quality of their physical health. SINGAPORE, May 25,...
DoctorOnCall Inks MoU with (Pertubuhan Doktor-Doktor Islam Malaysia) PERDIM to Bridge Healthcare Providers and Patients Through Digital Platform
The partnership will propel PERDIM's digital healthcare capabilities and increase revenue by offering an online database of healthcare products, services and treatments across the nation. KUALA LUMPUR, Malaysia, May 25, 2022 /PRNewswire/ -- Malaysia's first and largest digital health platform, H...
Brii Biosciences to be Added to MSCI China Small Cap Index
DURHAM, N.C. and BEIJING, May 25, 2022 /PRNewswire/ -- Brii Biosciences Limited
CJ BIO and NatureWorks Working Towards a Master Collaboration Agreement to Commercialize Novel Biopolymer Solutions
Companies announce signed letter of intent to collaborate on creating advanced products based on industry-leading Ingeo™ PLA and PHACT® PHA technologies to meet growing demand for sustainable materials across wide array of markets WOBURN, Mass. and PLYMOUTH, Minn., May 25, 2022 /PRNewswire/ -- CJ...
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
* Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. * The candidate is intended to be used for the treatment of SARS-CoV-2 and its variants, along with other coronaviruses. * ...
Vision Impact Institute Joins Partners to Bring Good Vision to Vulnerable Populations in Panama
Joint effort will expand access to vision care and deliver free eye care and services DALLAS, May 25, 2022 /PRNewswire/ -- The Vision Impact Institute (VII) is pleased to join a partnership that brings eye care services to vulnerable populations inPanama. The partnership includes Lions Club Peno...
ICP DAS - BMP will attend Medical Taiwan Expo 2022 in Taipei
TAIPEI, May 25, 2022 /PRNewswire/ -- ICP DAS - BMP (Biomedical Polymers), a Taiwanese medical TPU (thermoplastic polyurethane) supplier, will exhibit at Medical Taiwan 2022, an international medical, health, and care expo. The Medical Taiwan Expo 2022 will take place at the Taipei Nangang Exhibit...
Eurofins Discovery Announces Formation of its New Scientific Advisory Board
SAN DIEGO, May 24, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, today announced the formation of its new Scientific Advisory Board (SAB). Company officials gathered renowned lead...
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
* Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. * The candidate is intended to be used for the treatment of SARS-CoV-2 and its variants, along with other coronaviruses. Insi...
Travecta Therapeutics Announces In-Person Presentation at 2022 BIO International Convention
SINGAPORE and PRINCETON, N.J., May 24, 2022 /PRNewswire/ -- Travecta Therapeutics, Pte Ltd., a private biopharmaceutical company pioneering transformative treatments for serious neurological conditions by utilizing a natural transport system in the blood-brain barrier ("BBB") as a novel delivery ...
Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis
SHANGHAI, May 24, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) presented at Digestive Disease Week (DDW) 2022 detailed results from two pivotal studies that make up the ELEVATE UC Phase 3 registrational program evaluatin...
New Study Shows Critical Role of 1,5-Anhydroglucitol (1,5-AG) in COVID-19 Pathogenesis by Binding to the COVID-19 Spike Protein
Study Findings Support Data Presented on the GlycoMark Blood Test at the Most RecentADA and AHA Scientific Sessions RALEIGH, N.C., May 24, 2022 /PRNewswire/ -- Precision Diabetes, Inc. A new study recently published inNature Metabolism shows that 1,5-anhydroglucitol (1,5-AG), a glucose-like me...
DERMALOG and Rheinmetall join forces for increased vehicle security
With the founding of the joint venture Rheinmetall Dermalog SensorTec GmbH, the technology group Rheinmetall and the biometrics company DERMALOG are aiming to bring enhanced safety to road traffic. The objectives of the partnership include the development of a next-generation driver monitoring sy...
Nanoform 1Q 2022 report: Quarterly record of new projects and new customers
HELSINKI, May 24, 2022 /PRNewswire/ -- The positive momentum continues. A quarterly record of eight new non-GMP projects with seven different customers signed. Revenue grew by 174%, the number of employees by 49%, while the total operating costs grew by 27%. The gross margin rose to 92%. Signific...
Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma
* First study conducted in the adjuvant setting with a combination of BRAF and MEK inhibitors in high-risk stage II BRAF V600E/K-mutant cutaneous melanoma * A global partnership between EORTC and Pierre Fabre to advance research in melanoma CASTRES, France and BRUSSELS, May 24, 2022 /PRNewswir...
SwipeRx secures US$27 Million in Series B Funding to accelerate growth across Southeast Asia
SINGAPORE, May 24, 2022 /PRNewswire/ -- SwipeRx (formerly mClinica Pharmacy Solutions),Southeast Asia's (SEA) leading platform for pharmacies, announced it has secured a Series B round ofUS$27 million in equity and debt to accelerate growth across SEA. The round was led byIndonesia's MDI Ventures...
OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time
SAN JOSE, Calif., May 24, 2022 /PRNewswire/ -- OptraSCAN®
Week's Top Stories
Most Reposted
Rising Through the Ranks: Giti Recorded as the Fastest-Growing Tire Brand in the World, and They Are Not Stopping There
[Picked up by 311 media titles]
2024-06-12 15:34Tan Xuguang: Enter South Korea, Full Focus on Business in the "Doorstep" Market
[Picked up by 285 media titles]
2024-06-16 19:38Broad-Based ETFs Unleashing Opportunities to Invest in China A-Shares Amid Market Recovery
[Picked up by 238 media titles]
2024-06-11 10:06The Third Hong Kong Science Fair Gathers Creative Technologies of the Next Generation
[Picked up by 231 media titles]
2024-06-10 12:11Forrester: APAC Tech Spend To Grow 7% Annually, Reaching US $876 Billion In 2027
[Picked up by 224 media titles]
2024-06-11 12:07